Avg closing price
Price range

24 Joel Greenblatt Neurocrine Biosciences Trades

Joel Greenblatt acquired 5.54 Thousand Neurocrine Biosciences shares worth $763 Thousand. That's 0.01% of their equity portfolio (848th largest holding). The first Neurocrine Biosciences trade was made in Q1 2012. Since then Joel Greenblatt bought shares twelve more times and sold shares on eleven occasions. The stake costed the investor $529 Thousand, netting the investor a gain of 44% so far.

Avg closing price
Price range
Increased shares by 9.5% (+480 shares) Q4 2023
Avg closing price $115.11
Price range $106.07 - $132.76
Sold 6.6% shares (-355 shares) Q3 2023
Avg closing price $105.30
Price range $94.02 - $117.10
Sold 28.7% shares (-2.18 Thousand shares) Q2 2023
Avg closing price $97.71
Price range $89.53 - $104.87
Sold 3.0% shares (-236 shares) Q1 2023
Avg closing price $104.06
Price range $94.11 - $123.02
Increased shares by 39.2% (+2.2 Thousand shares) Q4 2022
Avg closing price $117.13
Price range $106.72 - $127.06
Increased shares by 0.5% (+29 shares) Q3 2022
Avg closing price $101.46
Price range $92.03 - $107.81
Sold 20.3% shares (-1.43 Thousand shares) Q2 2022
Avg closing price $92.29
Price range $75.79 - $100.07
Increased shares by 174.6% (+4.47 Thousand shares) Q1 2022
Avg closing price $84.75
Price range $72.45 - $94.81
New holding (+2.56 Thousand shares) Q4 2021
Avg closing price $91.99
Price range $79.65 - $106.22
Sold -18.7 Thousand shares Q4 2020
Avg closing price $96.59
Price range $86.91 - $108.33
Increased shares by 45.7% (+5.87 Thousand shares) Q3 2020
Avg closing price $115.68
Price range $96.16 - $135.15
Sold 33.1% shares (-6.36 Thousand shares) Q2 2020
Avg closing price $110.51
Price range $85.09 - $130.36
Sold 35.3% shares (-10.5 Thousand shares) Q1 2020
Avg closing price $97.87
Price range $75.11 - $113.76
Increased shares by 112.9% (+15.7 Thousand shares) Q4 2019
Avg closing price $104.70
Price range $86.80 - $118.57
Increased shares by 32.7% (+3.43 Thousand shares) Q3 2019
Avg closing price $93.43
Price range $83.82 - $101.50
Sold 45.7% shares (-8.83 Thousand shares) Q2 2019
Avg closing price $82.11
Price range $72.24 - $91.27
Increased shares by 18.1% (+2.96 Thousand shares) Q1 2019
Avg closing price $83.58
Price range $69.31 - $91.53
Sold 30.7% shares (-7.25 Thousand shares) Q4 2018
Avg closing price $95.81
Price range $68.32 - $124.36
Increased shares by 218.7% (+16.2 Thousand shares) Q3 2018
Avg closing price $113.46
Price range $98.88 - $125.85
New holding (+7.41 Thousand shares) Q2 2018
Avg closing price $89.51
Price range $75.30 - $105.99

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!